• Profile
Close

Amniotic immune biomarkers as risk factors in women with different symptoms of threatened late miscarriage

American Journal of Reproductive Immunology Mar 21, 2020

Meng L, Wang Z, Reilly M, et al. - Researchers sought the risk factors that can aid in recognition of the possibility of pregnancy loss in threatened late miscarriage (TLM) patients with and without spontaneous uterine contractions. They assayed amniotic immune biomarkers (IL2β receptor, IL6, IL8, IL10, IL1β, and TNFα) and assessed “sludge”. Treatment was provided to patients without intrauterine infections and followed‐up until delivery, and pregnancy outcomes were recorded. The group with contractions had higher amniotic levels of IL2βR, IL8, and TNFα. Among TLM patients without intrauterine infections, there were differences in amniotic immune biomarkers between patients with different symptoms; these differed not only for their levels but also for the impact of these biomarkers on the risk of late miscarriage. Findings thereby emphasize considering the symptoms of TLM in the study of miscarriage risk.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay